Northland Capmk Predicts Abacus Life Q1 Earnings

Abacus Life, Inc. (NASDAQ:ABL) – Research analysts at Northland Capmk issued their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a report released on Monday, November 25th. Northland Capmk analyst M. Grondahl forecasts that the company will post earnings per share of $0.15 for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.64 per share. Northland Capmk also issued estimates for Abacus Life’s Q2 2025 earnings at $0.18 EPS, Q3 2025 earnings at $0.21 EPS, Q4 2025 earnings at $0.24 EPS and FY2025 earnings at $0.78 EPS.

Other equities research analysts have also issued research reports about the company. B. Riley Financial restated a “buy” rating and set a $16.00 price target on shares of Abacus Life in a research note on Friday, August 30th. TD Cowen began coverage on Abacus Life in a research note on Wednesday, August 7th. They set a “buy” rating and a $14.00 price target on the stock. Piper Sandler restated an “overweight” rating and set a $13.00 price target (up previously from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. Northland Securities initiated coverage on Abacus Life in a report on Thursday, October 24th. They set an “outperform” rating and a $13.50 target price for the company. Finally, B. Riley lifted their target price on Abacus Life from $16.00 to $17.00 and gave the stock a “buy” rating in a report on Monday. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $14.70.

Abacus Life Stock Up 3.3 %

Shares of ABL stock opened at $8.08 on Thursday. The stock’s fifty day moving average price is $9.17 and its 200 day moving average price is $9.74. Abacus Life has a 1-year low of $6.56 and a 1-year high of $13.25. The company has a market cap of $603.17 million, a price-to-earnings ratio of -44.89 and a beta of 0.15. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29.

Abacus Life (NASDAQ:ABL) last announced its earnings results on Thursday, November 7th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.06. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The company had revenue of $28.15 million during the quarter, compared to the consensus estimate of $26.08 million. During the same period last year, the firm earned $0.01 earnings per share.

Insider Buying and Selling at Abacus Life

In other Abacus Life news, Director Adam Samuel Gusky bought 18,241 shares of Abacus Life stock in a transaction dated Friday, November 22nd. The stock was acquired at an average cost of $7.54 per share, with a total value of $137,537.14. Following the purchase, the director now directly owns 40,959 shares in the company, valued at $308,830.86. This represents a 80.29 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jay J. Jackson sold 2,031,250 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $8.00, for a total value of $16,250,000.00. Following the transaction, the chief executive officer now directly owns 10,562,000 shares of the company’s stock, valued at approximately $84,496,000. The trade was a 16.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 79.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Abacus Life

Several large investors have recently made changes to their positions in ABL. Renaissance Technologies LLC purchased a new stake in shares of Abacus Life during the second quarter worth approximately $106,000. Levin Capital Strategies L.P. purchased a new stake in Abacus Life in the 2nd quarter valued at $130,000. Richard W. Paul & Associates LLC grew its holdings in Abacus Life by 4.8% in the 2nd quarter. Richard W. Paul & Associates LLC now owns 30,448 shares of the company’s stock valued at $263,000 after buying an additional 1,401 shares in the last quarter. Quarry LP purchased a new stake in Abacus Life in the 2nd quarter valued at $318,000. Finally, Sei Investments Co. purchased a new stake in Abacus Life in the 2nd quarter valued at $418,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.